Concepts (258)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain | 31 | 2020 | 1032 | 2.220 |
Why?
|
| Magnetic Resonance Imaging | 33 | 2020 | 1393 | 1.550 |
Why?
|
| Image Processing, Computer-Assisted | 11 | 2017 | 260 | 0.900 |
Why?
|
| Auditory Perception | 7 | 2009 | 80 | 0.760 |
Why?
|
| Appetite | 2 | 2020 | 24 | 0.750 |
Why?
|
| Obesity | 7 | 2020 | 1246 | 0.750 |
Why?
|
| Brain Mapping | 16 | 2018 | 208 | 0.720 |
Why?
|
| Somatosensory Cortex | 2 | 2017 | 30 | 0.710 |
Why?
|
| Nerve Net | 9 | 2018 | 141 | 0.650 |
Why?
|
| Exercise | 5 | 2018 | 701 | 0.580 |
Why?
|
| Neuronal Plasticity | 2 | 2017 | 86 | 0.560 |
Why?
|
| Beta vulgaris | 2 | 2017 | 11 | 0.560 |
Why?
|
| Cerebral Infarction | 4 | 2008 | 25 | 0.560 |
Why?
|
| Visual Perception | 6 | 2009 | 122 | 0.520 |
Why?
|
| Visual Cortex | 6 | 2009 | 47 | 0.460 |
Why?
|
| Cerebrovascular Circulation | 9 | 2011 | 104 | 0.450 |
Why?
|
| Humans | 62 | 2020 | 34562 | 0.420 |
Why?
|
| Weight Loss | 4 | 2018 | 494 | 0.410 |
Why?
|
| Auditory Cortex | 4 | 2009 | 21 | 0.400 |
Why?
|
| Male | 40 | 2020 | 20740 | 0.380 |
Why?
|
| Cerebral Cortex | 5 | 2009 | 146 | 0.360 |
Why?
|
| Female | 38 | 2020 | 21532 | 0.360 |
Why?
|
| Aged | 25 | 2020 | 11022 | 0.350 |
Why?
|
| Adult | 34 | 2018 | 10030 | 0.330 |
Why?
|
| Aging | 6 | 2015 | 1010 | 0.320 |
Why?
|
| Music | 2 | 2007 | 6 | 0.300 |
Why?
|
| Acoustic Stimulation | 12 | 2018 | 122 | 0.290 |
Why?
|
| Career Mobility | 2 | 2019 | 18 | 0.290 |
Why?
|
| Attention | 3 | 2009 | 91 | 0.290 |
Why?
|
| Prefrontal Cortex | 2 | 2013 | 90 | 0.290 |
Why?
|
| Radiology | 2 | 2019 | 46 | 0.280 |
Why?
|
| Middle Aged | 27 | 2020 | 12726 | 0.280 |
Why?
|
| Faculty, Medical | 2 | 2019 | 81 | 0.280 |
Why?
|
| Perception | 2 | 2012 | 107 | 0.270 |
Why?
|
| Neural Inhibition | 1 | 2008 | 35 | 0.270 |
Why?
|
| Cognition | 4 | 2016 | 576 | 0.270 |
Why?
|
| Gyrus Cinguli | 2 | 2008 | 27 | 0.270 |
Why?
|
| Magnetic Resonance Angiography | 4 | 2011 | 79 | 0.270 |
Why?
|
| Spin Labels | 5 | 2011 | 27 | 0.260 |
Why?
|
| Auditory Pathways | 2 | 2006 | 10 | 0.250 |
Why?
|
| Image Enhancement | 3 | 2009 | 74 | 0.250 |
Why?
|
| Dyslexia | 2 | 2005 | 8 | 0.250 |
Why?
|
| Tomography, X-Ray | 1 | 2006 | 5 | 0.240 |
Why?
|
| Walking | 2 | 2017 | 217 | 0.230 |
Why?
|
| Overweight | 2 | 2018 | 289 | 0.230 |
Why?
|
| Image Interpretation, Computer-Assisted | 5 | 2018 | 115 | 0.220 |
Why?
|
| Caffeine | 4 | 2009 | 29 | 0.220 |
Why?
|
| Software | 3 | 2015 | 130 | 0.220 |
Why?
|
| Nicotine | 2 | 2017 | 179 | 0.210 |
Why?
|
| Pesticides | 2 | 2017 | 201 | 0.210 |
Why?
|
| Nitrates | 2 | 2017 | 29 | 0.210 |
Why?
|
| Reference Books, Medical | 1 | 2004 | 2 | 0.210 |
Why?
|
| Software Validation | 1 | 2004 | 4 | 0.210 |
Why?
|
| Medical Illustration | 1 | 2004 | 6 | 0.210 |
Why?
|
| Medical Informatics Applications | 1 | 2004 | 8 | 0.210 |
Why?
|
| Occupational Exposure | 2 | 2017 | 237 | 0.210 |
Why?
|
| Tomography, Emission-Computed | 1 | 2004 | 29 | 0.210 |
Why?
|
| Echo-Planar Imaging | 2 | 2009 | 15 | 0.210 |
Why?
|
| Perfusion | 1 | 2004 | 78 | 0.200 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2020 | 988 | 0.200 |
Why?
|
| Frontal Lobe | 1 | 2004 | 41 | 0.200 |
Why?
|
| Photic Stimulation | 10 | 2009 | 172 | 0.200 |
Why?
|
| Data Interpretation, Statistical | 1 | 2003 | 123 | 0.190 |
Why?
|
| Aged, 80 and over | 8 | 2020 | 4157 | 0.190 |
Why?
|
| Reaction Time | 5 | 2006 | 131 | 0.190 |
Why?
|
| Internet | 1 | 2004 | 207 | 0.180 |
Why?
|
| Resistance Training | 3 | 2018 | 84 | 0.180 |
Why?
|
| Parietal Lobe | 2 | 2013 | 17 | 0.170 |
Why?
|
| Education, Medical, Graduate | 2 | 2019 | 138 | 0.170 |
Why?
|
| Neural Pathways | 5 | 2017 | 116 | 0.160 |
Why?
|
| Oxygen | 5 | 2017 | 152 | 0.160 |
Why?
|
| Leukoencephalopathies | 1 | 2020 | 12 | 0.160 |
Why?
|
| Reproducibility of Results | 5 | 2009 | 823 | 0.150 |
Why?
|
| Double-Blind Method | 3 | 2017 | 597 | 0.150 |
Why?
|
| Mentors | 1 | 2019 | 35 | 0.150 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 98 | 0.140 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 103 | 0.140 |
Why?
|
| Memory, Short-Term | 2 | 2016 | 68 | 0.140 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2018 | 49 | 0.140 |
Why?
|
| Body Composition | 2 | 2017 | 415 | 0.140 |
Why?
|
| Dietary Supplements | 2 | 2017 | 198 | 0.130 |
Why?
|
| Pain | 2 | 2011 | 330 | 0.130 |
Why?
|
| Military Personnel | 1 | 2018 | 103 | 0.130 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2009 | 137 | 0.130 |
Why?
|
| Disability Evaluation | 1 | 2017 | 262 | 0.120 |
Why?
|
| Cerebrovascular Disorders | 2 | 2009 | 55 | 0.120 |
Why?
|
| Quality of Life | 3 | 2017 | 1032 | 0.120 |
Why?
|
| Cerebellum | 2 | 2013 | 27 | 0.120 |
Why?
|
| Psychomotor Performance | 3 | 2005 | 116 | 0.120 |
Why?
|
| Central Nervous System Stimulants | 2 | 2009 | 85 | 0.120 |
Why?
|
| Nitrites | 2 | 2017 | 22 | 0.120 |
Why?
|
| Nonlinear Dynamics | 1 | 2014 | 77 | 0.110 |
Why?
|
| Gambling | 1 | 2014 | 6 | 0.110 |
Why?
|
| Emigrants and Immigrants | 1 | 2017 | 248 | 0.100 |
Why?
|
| Alcohol Drinking | 1 | 2016 | 261 | 0.100 |
Why?
|
| Functional Laterality | 3 | 2011 | 66 | 0.100 |
Why?
|
| Brain Injuries | 2 | 2011 | 94 | 0.100 |
Why?
|
| Thalamus | 1 | 2013 | 39 | 0.100 |
Why?
|
| Hispanic Americans | 2 | 2017 | 948 | 0.100 |
Why?
|
| Analysis of Variance | 6 | 2011 | 508 | 0.100 |
Why?
|
| Choice Behavior | 1 | 2014 | 88 | 0.100 |
Why?
|
| Geriatric Assessment | 1 | 2015 | 369 | 0.100 |
Why?
|
| Motor Activity | 1 | 2015 | 356 | 0.100 |
Why?
|
| Risk Reduction Behavior | 1 | 2013 | 129 | 0.090 |
Why?
|
| Mobility Limitation | 1 | 2014 | 222 | 0.090 |
Why?
|
| Social Control, Informal | 1 | 2012 | 8 | 0.090 |
Why?
|
| Decision Making | 1 | 2014 | 203 | 0.090 |
Why?
|
| Food Preferences | 1 | 2012 | 36 | 0.090 |
Why?
|
| Corpus Callosum | 2 | 2020 | 18 | 0.090 |
Why?
|
| Putamen | 1 | 2011 | 28 | 0.090 |
Why?
|
| Holistic Health | 1 | 2011 | 7 | 0.080 |
Why?
|
| Diet | 2 | 2012 | 418 | 0.080 |
Why?
|
| Therapeutic Touch | 1 | 2011 | 10 | 0.080 |
Why?
|
| Comprehension | 1 | 2011 | 19 | 0.080 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2011 | 21 | 0.080 |
Why?
|
| Pruritus | 1 | 2011 | 47 | 0.080 |
Why?
|
| Young Adult | 6 | 2015 | 2831 | 0.080 |
Why?
|
| Cues | 3 | 2006 | 65 | 0.080 |
Why?
|
| Neuropsychological Tests | 4 | 2015 | 372 | 0.080 |
Why?
|
| Heart Failure | 1 | 2017 | 780 | 0.080 |
Why?
|
| Hypertension | 1 | 2017 | 1024 | 0.080 |
Why?
|
| Diagnosis, Differential | 3 | 2008 | 542 | 0.080 |
Why?
|
| Perfusion Imaging | 1 | 2009 | 8 | 0.070 |
Why?
|
| Database Management Systems | 1 | 2009 | 12 | 0.070 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2009 | 48 | 0.070 |
Why?
|
| Perceptual Disorders | 1 | 2009 | 8 | 0.070 |
Why?
|
| Brain Diseases | 1 | 2009 | 39 | 0.070 |
Why?
|
| Information Storage and Retrieval | 1 | 2009 | 28 | 0.070 |
Why?
|
| Models, Neurological | 2 | 2014 | 145 | 0.070 |
Why?
|
| Regression Analysis | 3 | 2017 | 310 | 0.070 |
Why?
|
| Epilepsy, Tonic-Clonic | 1 | 2008 | 8 | 0.070 |
Why?
|
| Cerebral Arteries | 1 | 2008 | 23 | 0.070 |
Why?
|
| Models, Biological | 1 | 2010 | 432 | 0.070 |
Why?
|
| Neurologic Examination | 2 | 2011 | 31 | 0.070 |
Why?
|
| Hemiplegia | 1 | 2007 | 12 | 0.070 |
Why?
|
| Retrospective Studies | 5 | 2017 | 3825 | 0.070 |
Why?
|
| Radiosurgery | 1 | 2011 | 361 | 0.070 |
Why?
|
| Arm | 1 | 2007 | 44 | 0.070 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2007 | 35 | 0.060 |
Why?
|
| Hand | 1 | 2007 | 80 | 0.060 |
Why?
|
| Coffee | 2 | 2003 | 8 | 0.060 |
Why?
|
| Rest | 2 | 2017 | 53 | 0.060 |
Why?
|
| Contrast Media | 2 | 2009 | 149 | 0.060 |
Why?
|
| Time Perception | 1 | 2006 | 7 | 0.060 |
Why?
|
| Cotinine | 2 | 2017 | 52 | 0.060 |
Why?
|
| Judgment | 1 | 2006 | 13 | 0.060 |
Why?
|
| Pitch Discrimination | 1 | 2005 | 1 | 0.060 |
Why?
|
| Diffusion | 2 | 2002 | 17 | 0.060 |
Why?
|
| Sensitivity and Specificity | 2 | 2009 | 614 | 0.060 |
Why?
|
| Discrimination Learning | 1 | 2005 | 20 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 1209 | 0.060 |
Why?
|
| Ischemic Attack, Transient | 1 | 2006 | 57 | 0.060 |
Why?
|
| Single-Blind Method | 3 | 2017 | 214 | 0.060 |
Why?
|
| Internship and Residency | 2 | 2019 | 330 | 0.060 |
Why?
|
| Muscle Strength | 2 | 2017 | 157 | 0.050 |
Why?
|
| Time Factors | 3 | 2006 | 2353 | 0.050 |
Why?
|
| Probability | 2 | 2017 | 168 | 0.050 |
Why?
|
| Adolescent | 5 | 2011 | 3805 | 0.050 |
Why?
|
| Blood Volume | 1 | 2004 | 9 | 0.050 |
Why?
|
| Evoked Potentials | 1 | 2003 | 19 | 0.050 |
Why?
|
| Myopia | 1 | 2003 | 5 | 0.050 |
Why?
|
| Sound Localization | 1 | 2003 | 7 | 0.050 |
Why?
|
| Arousal | 1 | 2003 | 20 | 0.050 |
Why?
|
| Terminology as Topic | 1 | 2004 | 71 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2005 | 926 | 0.050 |
Why?
|
| Brain Edema | 1 | 2003 | 16 | 0.050 |
Why?
|
| Stroke | 1 | 2009 | 700 | 0.050 |
Why?
|
| Cluster Analysis | 2 | 2014 | 128 | 0.050 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2003 | 25 | 0.050 |
Why?
|
| Age Factors | 3 | 2014 | 1262 | 0.050 |
Why?
|
| Psychophysiology | 1 | 2002 | 2 | 0.050 |
Why?
|
| Oxygen Consumption | 1 | 2003 | 167 | 0.050 |
Why?
|
| Gadolinium DTPA | 1 | 2002 | 16 | 0.050 |
Why?
|
| Dominance, Cerebral | 1 | 2002 | 12 | 0.050 |
Why?
|
| Hearing | 1 | 2002 | 10 | 0.050 |
Why?
|
| Language | 1 | 2002 | 45 | 0.050 |
Why?
|
| Research Design | 1 | 2004 | 337 | 0.040 |
Why?
|
| Acute Disease | 1 | 2002 | 277 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 2006 | 649 | 0.040 |
Why?
|
| Blood Flow Velocity | 2 | 2011 | 87 | 0.040 |
Why?
|
| Pain Threshold | 2 | 2011 | 105 | 0.040 |
Why?
|
| Organizational Objectives | 1 | 2019 | 28 | 0.040 |
Why?
|
| Pain Measurement | 2 | 2011 | 385 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 2367 | 0.030 |
Why?
|
| Statistics as Topic | 2 | 2009 | 111 | 0.030 |
Why?
|
| Regional Blood Flow | 2 | 2010 | 95 | 0.030 |
Why?
|
| Acetylcholinesterase | 1 | 2017 | 20 | 0.030 |
Why?
|
| Sensory Thresholds | 2 | 2009 | 30 | 0.030 |
Why?
|
| Butyrylcholinesterase | 1 | 2017 | 14 | 0.030 |
Why?
|
| Diet, Reducing | 1 | 2018 | 109 | 0.030 |
Why?
|
| Child | 3 | 2011 | 2614 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2016 | 3623 | 0.030 |
Why?
|
| Physical Endurance | 1 | 2017 | 42 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2015 | 1910 | 0.030 |
Why?
|
| Cholinesterases | 1 | 2016 | 10 | 0.030 |
Why?
|
| ROC Curve | 1 | 2016 | 176 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2017 | 193 | 0.030 |
Why?
|
| Behavior Therapy | 1 | 2016 | 107 | 0.030 |
Why?
|
| Exercise Therapy | 1 | 2018 | 283 | 0.030 |
Why?
|
| Psychometrics | 1 | 2015 | 143 | 0.030 |
Why?
|
| Information Theory | 1 | 2014 | 4 | 0.030 |
Why?
|
| Agriculture | 1 | 2016 | 195 | 0.030 |
Why?
|
| Life Style | 1 | 2016 | 418 | 0.030 |
Why?
|
| Behavior | 1 | 2013 | 31 | 0.030 |
Why?
|
| Personal Satisfaction | 1 | 2013 | 28 | 0.030 |
Why?
|
| Task Performance and Analysis | 1 | 2013 | 54 | 0.030 |
Why?
|
| Stroke Volume | 1 | 2017 | 440 | 0.030 |
Why?
|
| Reward | 1 | 2014 | 70 | 0.030 |
Why?
|
| Infant | 2 | 2009 | 1123 | 0.020 |
Why?
|
| Transients and Migrants | 1 | 2016 | 304 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2017 | 901 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2009 | 1355 | 0.020 |
Why?
|
| Reference Values | 2 | 2003 | 265 | 0.020 |
Why?
|
| Drive | 1 | 2012 | 2 | 0.020 |
Why?
|
| Postprandial Period | 1 | 2012 | 11 | 0.020 |
Why?
|
| Taste | 1 | 2012 | 18 | 0.020 |
Why?
|
| Bone Density | 1 | 2013 | 209 | 0.020 |
Why?
|
| Water | 1 | 2012 | 70 | 0.020 |
Why?
|
| Behavior, Addictive | 1 | 2012 | 40 | 0.020 |
Why?
|
| Caenorhabditis elegans | 1 | 2011 | 20 | 0.020 |
Why?
|
| North Carolina | 1 | 2016 | 1613 | 0.020 |
Why?
|
| Psychoacoustics | 1 | 2011 | 3 | 0.020 |
Why?
|
| Self Efficacy | 1 | 2012 | 79 | 0.020 |
Why?
|
| Energy Intake | 1 | 2012 | 138 | 0.020 |
Why?
|
| Afferent Pathways | 1 | 2011 | 42 | 0.020 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2011 | 56 | 0.020 |
Why?
|
| Random Allocation | 1 | 2011 | 257 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2012 | 168 | 0.020 |
Why?
|
| Hyperalgesia | 1 | 2011 | 86 | 0.020 |
Why?
|
| Mental Processes | 1 | 2010 | 16 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2011 | 380 | 0.020 |
Why?
|
| Saliva | 1 | 2009 | 41 | 0.020 |
Why?
|
| Risk Factors | 1 | 2017 | 4137 | 0.020 |
Why?
|
| Animals | 2 | 2011 | 8579 | 0.020 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2009 | 16 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2009 | 213 | 0.020 |
Why?
|
| Arteries | 1 | 2009 | 83 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2009 | 89 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 755 | 0.020 |
Why?
|
| Motor Skills | 1 | 2007 | 16 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 2009 | 160 | 0.020 |
Why?
|
| Movement | 1 | 2007 | 63 | 0.020 |
Why?
|
| Fingers | 1 | 2007 | 78 | 0.020 |
Why?
|
| Algorithms | 1 | 2010 | 561 | 0.020 |
Why?
|
| Organ Size | 1 | 2007 | 236 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2008 | 200 | 0.020 |
Why?
|
| Visual Pathways | 1 | 2006 | 42 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2007 | 251 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 2005 | 58 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2008 | 439 | 0.010 |
Why?
|
| Cerebral Ventriculography | 1 | 2003 | 3 | 0.010 |
Why?
|
| Subarachnoid Space | 1 | 2003 | 5 | 0.010 |
Why?
|
| Intracranial Pressure | 1 | 2003 | 17 | 0.010 |
Why?
|
| Fixation, Ocular | 1 | 2002 | 6 | 0.010 |
Why?
|
| Linear Models | 1 | 2003 | 465 | 0.010 |
Why?
|
| Acetazolamide | 1 | 2002 | 1 | 0.010 |
Why?
|
| Anisotropy | 1 | 2002 | 13 | 0.010 |
Why?
|
| Cadaver | 1 | 2002 | 170 | 0.010 |
Why?
|